Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $102.64 billion. The enterprise value is $92.15 billion.
| Market Cap | 102.64B |
| Enterprise Value | 92.15B |
Important Dates
The next confirmed earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 258.31 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Shares Outstanding | 258.31M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 97.33% |
| Float | 257.56M |
Valuation Ratios
The trailing PE ratio is 28.61 and the forward PE ratio is 23.23. VRTX's PEG ratio is 0.53.
| PE Ratio | 28.61 |
| Forward PE | 23.23 |
| PS Ratio | 10.40 |
| Forward PS | 9.39 |
| PB Ratio | 5.84 |
| P/FCF Ratio | 30.76 |
| PEG Ratio | 0.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.01, with an EV/FCF ratio of 27.61.
| EV / Earnings | 25.46 |
| EV / Sales | 9.34 |
| EV / EBITDA | 20.01 |
| EV / EBIT | 20.83 |
| EV / FCF | 27.61 |
Financial Position
The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.99 |
| Quick Ratio | 3.60 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.22 |
| Interest Coverage | 100.32 |
Financial Efficiency
Return on equity (ROE) is 22.60% and return on invested capital (ROIC) is 17.07%.
| Return on Equity (ROE) | 22.60% |
| Return on Assets (ROA) | 17.30% |
| Return on Capital (ROIC) | 17.07% |
| Revenue Per Employee | $1.83M |
| Profits Per Employee | $670,296 |
| Employee Count | 5,400 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.10 |
Taxes
In the past 12 months, VRTX has paid $760.20 million in taxes.
| Income Tax | 760.20M |
| Effective Tax Rate | 17.36% |
Stock Price Statistics
The stock price has increased by +21.24% in the last 52 weeks. The beta is 0.37, so VRTX's price volatility has been lower than the market average.
| Beta (1Y) | 0.37 |
| 52-Week Price Change | +21.24% |
| 50-Day Moving Average | 415.99 |
| 200-Day Moving Average | 381.22 |
| Relative Strength Index (RSI) | 35.25 |
| Average Volume (30 Days) | 1,264,872 |
Short Selling Information
The latest short interest is 3.98 million, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 3.98M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 1.54% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 3.84 |
Income Statement
In the last 12 months, VRTX had revenue of $9.87 billion and earned $3.62 billion in profits. Earnings per share was $13.89.
| Revenue | 9.87B |
| Gross Profit | 8.61B |
| Operating Income | 3.78B |
| Pretax Income | 4.38B |
| Net Income | 3.62B |
| EBITDA | 4.61B |
| EBIT | 4.42B |
| Earnings Per Share (EPS) | $13.89 |
Balance Sheet
The company has $11.22 billion in cash and $724.70 million in debt, giving a net cash position of $10.49 billion or $40.62 per share.
| Cash & Cash Equivalents | 11.22B |
| Total Debt | 724.70M |
| Net Cash | 10.49B |
| Net Cash Per Share | $40.62 |
| Equity / Book Value | 17.58B |
| Book Value Per Share | 68.06 |
| Working Capital | 10.60B |
Cash Flow
In the last 12 months, operating cash flow was $3.54 billion and capital expenditures -$200.40 million, giving a free cash flow of $3.34 billion.
| Operating Cash Flow | 3.54B |
| Capital Expenditures | -200.40M |
| Free Cash Flow | 3.34B |
| FCF Per Share | $12.95 |
Margins
Gross margin is 87.21%, with operating and profit margins of 38.31% and 36.68%.
| Gross Margin | 87.21% |
| Operating Margin | 38.31% |
| Pretax Margin | 44.38% |
| Profit Margin | 36.68% |
| EBITDA Margin | 46.66% |
| EBIT Margin | 44.83% |
| FCF Margin | 33.81% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.54% |
| Earnings Yield | 3.53% |
| FCF Yield | 3.25% |
Analyst Forecast
The average price target for VRTX is $425.95, which is 7.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $425.95 |
| Price Target Difference | 7.20% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (5Y) | 8.69% |
| EPS Growth Forecast (5Y) | 10.52% |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 14.22 and a Piotroski F-Score of 4.
| Altman Z-Score | 14.22 |
| Piotroski F-Score | 4 |